Discovery of an IKK2 Site that Allosterically Controls Its Activation | bioRxiv
Targeting IκappaB kinases for cancer therapy. - Abstract - Europe PMC
NF-kB inhibitors and activators | Abcam
Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases | Pharmaceutical Patent Analyst
I Kappa B Kinase Inhibitor - an overview | ScienceDirect Topics
A List of Different NF-JB Inhibitors, Mechanism of Action, and... | Download Table
The IKK NF-κB system: a treasure trove for drug development | Nature Reviews Drug Discovery
Frontiers | NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients | Immunology
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic | HTML
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation | PLOS Biology
Summary of p38 inhibitors in clinical trials. | Download Table
BET inhibitors in the treatment of hematologic malignancies: current i | OTT
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic | HTML
IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2022
The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis - Gynecologic Oncology
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic | HTML
Frontiers | Pharmacological Inhibitors of the NLRP3 Inflammasome | Immunology
The anti-tumor function of the IKK inhibitor PS1145 and high levels of p65 and KLF4 are associated with the drug resistance in nasopharyngeal carcinoma cells | Scientific Reports
NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors | SpringerLink
Targeting IKKα kinase to prevent tumor progression and therapy resistance
NF-κB inhibitor, NEMO-binding domain peptide attenuates intervertebral disc degeneration - The Spine Journal
Transcription Factor Inhibition: Lessons Learned and Emerging Targets: Trends in Molecular Medicine
Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma | Cell Death Discovery
